NEW YORK (GenomeWeb News) – Exact Sciences said today that it is undertaking a number of cost-reduction efforts, including laying off eight employees and suspending validation studies of its Version 2 stool-based technology for colorectal cancer screening, in an effort to conserve cash while “pursuing a strategic alternative for the business.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.